Tag: Featured Story

Vireo Growth’s proposed acquisition of Planet 13 would add 36 dispensaries, a high-profile Las Vegas superstore, and greater density in Florida. But the all-stock deal comes as Planet 13 reports declining revenue, widening losses, and a narrower operating footprint. The assets offer clear strategic value, yet Vireo’s projected scale, including roughly 265 dispensaries across fifteen states, depends on multiple transactions closing and integrating successfully.

Cannabis manufacturers often respond to sluggish throughput by investing in faster extraction equipment. But the true constraint may lie in solvent recovery, chilling capacity, facility layout, or operator workflow. Identifying and removing the actual bottleneck can improve cannabinoid recovery, increase production capacity, and provide the operational certainty customers, lenders, and investors expect.

Cannabis banks continue monitoring deposits, sales, licenses, ownership, and compliance after an account opens. Medical marijuana’s move to Schedule III may add new documentation and reporting questions, especially for businesses serving both medical and adult-use markets. Here, two bankers advise how to strengthen your banking relationship and avoid common pitfalls during the rescheduling transition.

You’ve tried the AI tools. Maybe you got some good results early on. Then something changed. The model updated, the context disappeared, or the output stopped making sense, and you were back to square one. Sound familiar? You’re not alone. In many cases, the problem isn’t the tool. It’s the workflow.

Cannabis investors and lenders have not disappeared, but their expectations have changed. Operators seeking capital now must demonstrate clean financials, positive cash flow, disciplined management, and a business model that works under current market and regulatory conditions — not one dependent on eventual federal reform.

Rosin’s resilience suggests some concentrate consumers are looking beyond THC percentages and paying closer attention to extraction methods, terpene preservation, lab results, and overall product quality. Retailers that train frontline staff to explain those differences can strengthen customer trust, defend premium pricing, and capture more value from the category.

A malfunctioning vape creates costs far beyond replacing the device. Returns, troubleshooting, production delays, and questions from retail partners all consume staff time. Cannabis brands can reduce that operational drag by evaluating oil-device compatibility, quality controls, traceability, inventory reliability, and consistency across production runs.

Legacy, passion, quality, craft, and deep roots appear so often in cannabis brand copy that they have lost much of their power to differentiate. Stronger positioning requires more than familiar adjectives. Brands need tension, specificity, and a clear point of view that gives customers, investors, and journalists something distinct to remember.

Federal rescheduling may accelerate two distinct THC economies: a pharmaceutical channel built around federally regulated medicines and a state-licensed consumer market built around retail, experience, and brand. The more immediate business question may be what happens when intoxicating-hemp consumers need somewhere else to shop.

Natural blue is one of food science’s most stubborn formulation problems. As major food companies continue searching for scalable replacements for synthetic dyes, cannabis ingredients supplier Melt-to-Make spent years working through the same problem. Its resulting natural-blue gummies offer a small but satisfying reminder that cannabis innovation does not always follow the lead of mainstream consumer packaged goods. Sometimes, it gets there first.